Active substances

Serenoa repens›

G04CX02 Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Other drugs used in benign prostatic hypertrophy

Indicated for: urinary symptoms in benign prostatic hyperplasia

Serplulimab›

L01FF12 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Indicated for: cancer

Sertindole›

N05AE03 Nervous system | Antipsychotics | Indole derivatives

Indicated for: schizophrenia; bipolar disorder

Sertraline›

N06AB06 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors

Indicated for: depression; anxiety disorders

Sevelamer›

V03AE02 Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Indicated for: hyperphosphatemia

Sevoflurane›

N01AB08 Nervous system | Anesthetics | Anesthetics, general | Halogenated hydrocarbons

Indicated for: general anesthesia; procedural sedation

Sibutramine›

A08AA10 Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Centrally acting antiobesity products

Indicated for: obesity; weight management

Sildenafil›

G04BE03 Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs used in erectile dysfunction

Indicated for: erectile dysfunction; pulmonary arterial hypertension

Silodosin›

G04CA04 Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists

Indicated for: benign prostatic hyperplasia

Siltuximab›

L04AC11 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors

Indicated for: cancer

Silver sulfadiazine + cerium nitrate›

D06BA51 Dermatologicals | Chemotherapeutics for topical use | Sulfonamides

Indicated for: angina pectoris

Silybin›

A05BA03 Alimentary tract and metabolism | Liver therapy, lipotropics

Indicated for: hepatobiliary disorders

Simeprevir›

J05AE14 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Indicated for: chronic hepatitis C

Simethicone›

A03AX13 Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Drugs for functional gastrointestinal disorders | Other drugs for functional gastrointestinal disorders

Indicated for: gastrointestinal spasms; functional abdominal pain

Simoctocog alfa (coagulation factor VIII)›

B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Indicated for: bleeding; coagulation disorders

Simvastatin›

C10AA01 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors

Indicated for: dyslipidemia

Siponimod›

L04AE03 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Sphingosine-1-phosphate (S1P) receptor modulators

Indicated for: multiple sclerosis

Sirolimus›

L04AA10 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Indicated for: prevention of transplant rejection

Sitagliptin›

A10BH01 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Dipeptidyl peptidase 4 (DDP-4) inhibitors

Indicated for: type 2 diabetes mellitus

Sitagliptin + dapagliflozin›

A10BD29 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Indicated for: type 2 diabetes mellitus

Sitagliptin + metformin›

A10BD07 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Indicated for: type 2 diabetes mellitus

Sitaxentan›

C02KX03 Cardiovascular system | Other antihypertensives | Antihypertensives for pulmonary arterial hypertension

Indicated for: pulmonary arterial hypertension

Sodium alginate + sodium bicarbonate›

A02BX13 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

Indicated for: gastroesophageal reflux; acid dyspepsia

Sodium alginate + sodium hydrogen carbonate + calcium carbonate›

A02BX13 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

Indicated for: gastroesophageal reflux; acid dyspepsia

Sodium amidotryzoate›

V08AA01 Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, high osmolar x-ray contrast media

Indicated for: diagnostic imaging contrast enhancement

Sodium aurothiomalate›

M01CB01 Musculo-skeletal system | Specific antirheumatic agents | Gold preparations

Indicated for: rheumatoid arthritis

Sodium chloride›

B05BB01 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Indicated for: electrolyte imbalance

Sodium chloride + potassium chloride + calcium chloride›

B05BB01 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Indicated for: fluid and electrolyte replacement

Sodium chloride + potassium chloride + calcium chloride + magnesium chloride + sodium acetate + glucose›

B05BB02 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Indicated for: fluid and electrolyte replacement with carbohydrate supply

Sodium chloride + potassium chloride + calcium chloride + sodium lactate›

B05BB01 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Indicated for: fluid and electrolyte replacement; mild metabolic acidosis